Structure

Physi-Chem Properties

Molecular Weight:  636.21
Volume:  595.415
LogP:  1.354
LogD:  1.17
LogS:  -4.103
# Rotatable Bonds:  9
TPSA:  216.2
# H-Bond Aceptor:  15
# H-Bond Donor:  6
# Rings:  5
# Heavy Atoms:  15

MedChem Properties

QED Drug-Likeness Score:  0.175
Synthetic Accessibility Score:  4.614
Fsp3:  0.5
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.219
MDCK Permeability:  5.2010400395374745e-05
Pgp-inhibitor:  0.025
Pgp-substrate:  0.997
Human Intestinal Absorption (HIA):  0.805
20% Bioavailability (F20%):  0.001
30% Bioavailability (F30%):  0.986

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.113
Plasma Protein Binding (PPB):  66.63922119140625%
Volume Distribution (VD):  0.648
Pgp-substrate:  18.161439895629883%

ADMET: Metabolism

CYP1A2-inhibitor:  0.025
CYP1A2-substrate:  0.98
CYP2C19-inhibitor:  0.03
CYP2C19-substrate:  0.634
CYP2C9-inhibitor:  0.006
CYP2C9-substrate:  0.188
CYP2D6-inhibitor:  0.033
CYP2D6-substrate:  0.543
CYP3A4-inhibitor:  0.021
CYP3A4-substrate:  0.035

ADMET: Excretion

Clearance (CL):  2.036
Half-life (T1/2):  0.445

ADMET: Toxicity

hERG Blockers:  0.608
Human Hepatotoxicity (H-HT):  0.174
Drug-inuced Liver Injury (DILI):  0.78
AMES Toxicity:  0.485
Rat Oral Acute Toxicity:  0.017
Maximum Recommended Daily Dose:  0.017
Skin Sensitization:  0.166
Carcinogencity:  0.158
Eye Corrosion:  0.003
Eye Irritation:  0.019
Respiratory Toxicity:  0.052

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC475366

Natural Product ID:  NPC475366
Common Name*:   5,7,4'-Trimethoxyflavone-7-O-Glucorhamnoside
IUPAC Name:   2-(3,4-dimethoxyphenyl)-5-methoxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one
Synonyms:  
Standard InCHIKey:  BZSRRACZBYSKRB-UPMDXQIVSA-N
Standard InCHI:  InChI=1S/C30H36O15/c1-12-23(32)25(34)27(36)29(42-12)41-11-21-24(33)26(35)28(37)30(45-21)43-14-8-19(40-4)22-15(31)10-17(44-20(22)9-14)13-5-6-16(38-2)18(7-13)39-3/h5-10,12,21,23-30,32-37H,11H2,1-4H3/t12-,21-,23-,24-,25+,26+,27-,28-,29+,30-/m1/s1
SMILES:  COc1cc(O[C@@H]2O[C@H](CO[C@H]3O[C@H](C)[C@H]([C@@H]([C@H]3O)O)O)[C@H]([C@@H]([C@H]2O)O)O)cc2c1c(=O)cc(o2)c1ccc(c(c1)OC)OC
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL504375
PubChem CID:   44575347
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000334] Flavonoids
        • [CHEMONTID:0001111] Flavonoid glycosides
          • [CHEMONTID:0001583] Flavonoid O-glycosides
            • [CHEMONTID:0003533] Flavonoid-7-O-glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO23424 Dirca palustris Species Thymelaeaceae Eukaryota n.a. n.a. n.a. PMID[10579873]
NPO23424 Dirca palustris Species Thymelaeaceae Eukaryota n.a. n.a. n.a. PMID[26225905]
NPO23424 Dirca palustris Species Thymelaeaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT35 Others n.a. Inhibition = 67.0 % PMID[456380]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC475366 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC475497
1.0 High Similarity NPC284277
0.9872 High Similarity NPC15358
0.981 High Similarity NPC195257
0.981 High Similarity NPC209296
0.9806 High Similarity NPC182045
0.9742 High Similarity NPC110349
0.9688 High Similarity NPC475155
0.9686 High Similarity NPC86008
0.9686 High Similarity NPC61791
0.9686 High Similarity NPC293629
0.9684 High Similarity NPC210073
0.9684 High Similarity NPC115674
0.9682 High Similarity NPC309025
0.9682 High Similarity NPC88023
0.9682 High Similarity NPC243930
0.9627 High Similarity NPC208668
0.9627 High Similarity NPC204693
0.9625 High Similarity NPC44328
0.9625 High Similarity NPC177731
0.9625 High Similarity NPC293004
0.9625 High Similarity NPC79056
0.9625 High Similarity NPC231194
0.9625 High Similarity NPC105095
0.9625 High Similarity NPC51326
0.962 High Similarity NPC311830
0.962 High Similarity NPC22832
0.9568 High Similarity NPC473327
0.9568 High Similarity NPC198199
0.9568 High Similarity NPC476472
0.9568 High Similarity NPC19108
0.9568 High Similarity NPC220173
0.9568 High Similarity NPC294815
0.9568 High Similarity NPC16194
0.9565 High Similarity NPC256760
0.9565 High Similarity NPC180918
0.9563 High Similarity NPC43587
0.956 High Similarity NPC5778
0.956 High Similarity NPC236934
0.956 High Similarity NPC8856
0.9557 High Similarity NPC284960
0.9557 High Similarity NPC19709
0.9557 High Similarity NPC191306
0.9557 High Similarity NPC222936
0.9557 High Similarity NPC270335
0.9548 High Similarity NPC473657
0.9548 High Similarity NPC295613
0.9509 High Similarity NPC48984
0.9503 High Similarity NPC67105
0.9503 High Similarity NPC285197
0.9503 High Similarity NPC150767
0.9503 High Similarity NPC52353
0.9503 High Similarity NPC95866
0.9503 High Similarity NPC78734
0.9503 High Similarity NPC194483
0.95 High Similarity NPC229729
0.95 High Similarity NPC135345
0.9494 High Similarity NPC77660
0.9494 High Similarity NPC473043
0.9494 High Similarity NPC189142
0.9451 High Similarity NPC173837
0.9451 High Similarity NPC475261
0.9451 High Similarity NPC251417
0.9451 High Similarity NPC89052
0.9451 High Similarity NPC120952
0.9448 High Similarity NPC102028
0.9444 High Similarity NPC60735
0.9444 High Similarity NPC203259
0.9444 High Similarity NPC267254
0.9444 High Similarity NPC33054
0.9444 High Similarity NPC261254
0.9444 High Similarity NPC471748
0.9444 High Similarity NPC176740
0.9444 High Similarity NPC471725
0.9444 High Similarity NPC3583
0.9444 High Similarity NPC26230
0.9444 High Similarity NPC155877
0.9444 High Similarity NPC259152
0.9444 High Similarity NPC134532
0.9441 High Similarity NPC472383
0.9441 High Similarity NPC226294
0.9441 High Similarity NPC229687
0.9441 High Similarity NPC203050
0.9441 High Similarity NPC219904
0.9441 High Similarity NPC472381
0.9441 High Similarity NPC58053
0.9441 High Similarity NPC186807
0.9441 High Similarity NPC475942
0.9441 High Similarity NPC105025
0.9441 High Similarity NPC469931
0.9441 High Similarity NPC223747
0.9441 High Similarity NPC105283
0.9441 High Similarity NPC227508
0.9441 High Similarity NPC45638
0.9441 High Similarity NPC120099
0.9441 High Similarity NPC225434
0.9441 High Similarity NPC201292
0.9441 High Similarity NPC93337
0.9437 High Similarity NPC197285
0.9437 High Similarity NPC21100
0.9434 High Similarity NPC29830
0.9434 High Similarity NPC168822
0.9427 High Similarity NPC138811
0.9427 High Similarity NPC22062
0.9427 High Similarity NPC473634
0.9394 High Similarity NPC473571
0.9394 High Similarity NPC192539
0.9394 High Similarity NPC126784
0.9394 High Similarity NPC470444
0.9394 High Similarity NPC470443
0.9394 High Similarity NPC473895
0.9394 High Similarity NPC473682
0.9394 High Similarity NPC110941
0.9394 High Similarity NPC241423
0.939 High Similarity NPC14187
0.939 High Similarity NPC169733
0.939 High Similarity NPC122467
0.939 High Similarity NPC202908
0.939 High Similarity NPC219043
0.939 High Similarity NPC292019
0.939 High Similarity NPC255799
0.939 High Similarity NPC471669
0.939 High Similarity NPC89127
0.9387 High Similarity NPC51774
0.9387 High Similarity NPC25724
0.9387 High Similarity NPC239549
0.9387 High Similarity NPC472993
0.9387 High Similarity NPC236191
0.9383 High Similarity NPC255157
0.9383 High Similarity NPC254855
0.9383 High Similarity NPC22195
0.9383 High Similarity NPC183357
0.9383 High Similarity NPC136042
0.9383 High Similarity NPC206123
0.9383 High Similarity NPC67326
0.9383 High Similarity NPC259896
0.9383 High Similarity NPC105511
0.9383 High Similarity NPC218488
0.9383 High Similarity NPC156869
0.9383 High Similarity NPC21190
0.9383 High Similarity NPC29958
0.9383 High Similarity NPC44558
0.9379 High Similarity NPC45618
0.9379 High Similarity NPC265530
0.9379 High Similarity NPC58716
0.9379 High Similarity NPC173637
0.9379 High Similarity NPC477502
0.9379 High Similarity NPC127546
0.9379 High Similarity NPC317489
0.9379 High Similarity NPC52550
0.9379 High Similarity NPC45400
0.9379 High Similarity NPC146792
0.9379 High Similarity NPC223424
0.9379 High Similarity NPC275454
0.9379 High Similarity NPC226304
0.9379 High Similarity NPC84362
0.9379 High Similarity NPC325555
0.9379 High Similarity NPC93099
0.9375 High Similarity NPC277205
0.9371 High Similarity NPC300537
0.9371 High Similarity NPC127782
0.9367 High Similarity NPC473623
0.9363 High Similarity NPC129827
0.9363 High Similarity NPC44931
0.9363 High Similarity NPC65003
0.9363 High Similarity NPC473512
0.9329 High Similarity NPC294629
0.9329 High Similarity NPC142996
0.9325 High Similarity NPC301683
0.9325 High Similarity NPC205076
0.9325 High Similarity NPC156977
0.9325 High Similarity NPC476405
0.9325 High Similarity NPC472386
0.9325 High Similarity NPC307518
0.9325 High Similarity NPC211594
0.9325 High Similarity NPC117260
0.9325 High Similarity NPC48773
0.9325 High Similarity NPC235575
0.9325 High Similarity NPC254540
0.9325 High Similarity NPC172807
0.9325 High Similarity NPC153755
0.9321 High Similarity NPC95855
0.9321 High Similarity NPC270578
0.9321 High Similarity NPC210042
0.9321 High Similarity NPC112755
0.9321 High Similarity NPC170675
0.9321 High Similarity NPC471457
0.9321 High Similarity NPC52382
0.9317 High Similarity NPC88789
0.9317 High Similarity NPC145038
0.9317 High Similarity NPC253662
0.9317 High Similarity NPC113968
0.9317 High Similarity NPC118284
0.9317 High Similarity NPC179950
0.9317 High Similarity NPC277174
0.9317 High Similarity NPC70441
0.9317 High Similarity NPC73855
0.9317 High Similarity NPC328940
0.9317 High Similarity NPC281131
0.9317 High Similarity NPC135599

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC475366 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.981 High Similarity NPD7054 Approved
0.9748 High Similarity NPD7472 Approved
0.9625 High Similarity NPD7074 Phase 3
0.9568 High Similarity NPD7808 Phase 3
0.9506 High Similarity NPD7251 Discontinued
0.9444 High Similarity NPD6797 Phase 2
0.9141 High Similarity NPD3818 Discontinued
0.9119 High Similarity NPD4381 Clinical (unspecified phase)
0.9096 High Similarity NPD4338 Clinical (unspecified phase)
0.9085 High Similarity NPD7804 Clinical (unspecified phase)
0.9018 High Similarity NPD6167 Clinical (unspecified phase)
0.9018 High Similarity NPD6166 Phase 2
0.9018 High Similarity NPD6168 Clinical (unspecified phase)
0.8875 High Similarity NPD3817 Phase 2
0.8868 High Similarity NPD1934 Approved
0.8696 High Similarity NPD2393 Clinical (unspecified phase)
0.8696 High Similarity NPD2801 Approved
0.8509 High Similarity NPD4380 Phase 2
0.8481 Intermediate Similarity NPD1511 Approved
0.8434 Intermediate Similarity NPD5494 Approved
0.8375 Intermediate Similarity NPD1512 Approved
0.8372 Intermediate Similarity NPD6559 Discontinued
0.8364 Intermediate Similarity NPD3882 Suspended
0.8364 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8354 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8313 Intermediate Similarity NPD7075 Discontinued
0.8242 Intermediate Similarity NPD7819 Suspended
0.8208 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8193 Intermediate Similarity NPD5402 Approved
0.8182 Intermediate Similarity NPD6801 Discontinued
0.8153 Intermediate Similarity NPD2796 Approved
0.8137 Intermediate Similarity NPD6799 Approved
0.8101 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8101 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8098 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.8098 Intermediate Similarity NPD5403 Approved
0.8092 Intermediate Similarity NPD5844 Phase 1
0.8086 Intermediate Similarity NPD5401 Approved
0.8086 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8084 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8059 Intermediate Similarity NPD7199 Phase 2
0.8059 Intermediate Similarity NPD6959 Discontinued
0.805 Intermediate Similarity NPD1549 Phase 2
0.8049 Intermediate Similarity NPD1653 Approved
0.8035 Intermediate Similarity NPD7228 Approved
0.8012 Intermediate Similarity NPD7411 Suspended
0.8012 Intermediate Similarity NPD3787 Discontinued
0.7977 Intermediate Similarity NPD7473 Discontinued
0.7966 Intermediate Similarity NPD8313 Approved
0.7966 Intermediate Similarity NPD8312 Approved
0.7956 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7955 Intermediate Similarity NPD7685 Pre-registration
0.7931 Intermediate Similarity NPD3751 Discontinued
0.7917 Intermediate Similarity NPD8455 Phase 2
0.7917 Intermediate Similarity NPD1465 Phase 2
0.7907 Intermediate Similarity NPD6232 Discontinued
0.7866 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7862 Intermediate Similarity NPD1510 Phase 2
0.7861 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7853 Intermediate Similarity NPD7240 Approved
0.7844 Intermediate Similarity NPD6599 Discontinued
0.7785 Intermediate Similarity NPD1933 Approved
0.7764 Intermediate Similarity NPD7266 Discontinued
0.7751 Intermediate Similarity NPD37 Approved
0.7747 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7733 Intermediate Similarity NPD919 Approved
0.7719 Intermediate Similarity NPD4966 Approved
0.7719 Intermediate Similarity NPD4967 Phase 2
0.7719 Intermediate Similarity NPD4965 Approved
0.7714 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7708 Intermediate Similarity NPD8151 Discontinued
0.7707 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7697 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7696 Intermediate Similarity NPD7584 Approved
0.7657 Intermediate Similarity NPD3926 Phase 2
0.7644 Intermediate Similarity NPD1247 Approved
0.763 Intermediate Similarity NPD6234 Discontinued
0.7622 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.761 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.761 Intermediate Similarity NPD1613 Approved
0.761 Intermediate Similarity NPD1240 Approved
0.7607 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7582 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7566 Intermediate Similarity NPD6776 Approved
0.7566 Intermediate Similarity NPD6778 Approved
0.7566 Intermediate Similarity NPD6782 Approved
0.7566 Intermediate Similarity NPD6777 Approved
0.7566 Intermediate Similarity NPD6781 Approved
0.7566 Intermediate Similarity NPD6780 Approved
0.7566 Intermediate Similarity NPD6779 Approved
0.7539 Intermediate Similarity NPD7435 Discontinued
0.7539 Intermediate Similarity NPD7696 Phase 3
0.7539 Intermediate Similarity NPD7697 Approved
0.7539 Intermediate Similarity NPD7698 Approved
0.7538 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7538 Intermediate Similarity NPD7783 Phase 2
0.7516 Intermediate Similarity NPD1607 Approved
0.7515 Intermediate Similarity NPD3750 Approved
0.7515 Intermediate Similarity NPD4628 Phase 3
0.7514 Intermediate Similarity NPD7768 Phase 2
0.7474 Intermediate Similarity NPD7701 Phase 2
0.7455 Intermediate Similarity NPD6674 Discontinued
0.7453 Intermediate Similarity NPD447 Suspended
0.7423 Intermediate Similarity NPD3748 Approved
0.7421 Intermediate Similarity NPD3027 Phase 3
0.7409 Intermediate Similarity NPD7871 Phase 2
0.7409 Intermediate Similarity NPD7870 Phase 2
0.7396 Intermediate Similarity NPD6823 Phase 2
0.7391 Intermediate Similarity NPD943 Approved
0.7378 Intermediate Similarity NPD1551 Phase 2
0.7371 Intermediate Similarity NPD3749 Approved
0.7368 Intermediate Similarity NPD7699 Phase 2
0.7368 Intermediate Similarity NPD7700 Phase 2
0.7368 Intermediate Similarity NPD7458 Discontinued
0.7358 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7358 Intermediate Similarity NPD6832 Phase 2
0.7353 Intermediate Similarity NPD920 Approved
0.7349 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7346 Intermediate Similarity NPD230 Phase 1
0.7341 Intermediate Similarity NPD6844 Discontinued
0.7333 Intermediate Similarity NPD7583 Approved
0.7316 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.731 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.731 Intermediate Similarity NPD7874 Approved
0.7302 Intermediate Similarity NPD6535 Approved
0.7302 Intermediate Similarity NPD6534 Approved
0.7296 Intermediate Similarity NPD7585 Approved
0.7296 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7292 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD7801 Approved
0.7273 Intermediate Similarity NPD2935 Discontinued
0.7262 Intermediate Similarity NPD6190 Approved
0.7257 Intermediate Similarity NPD5353 Approved
0.7246 Intermediate Similarity NPD1243 Approved
0.7246 Intermediate Similarity NPD1652 Phase 2
0.7244 Intermediate Similarity NPD1091 Approved
0.724 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7235 Intermediate Similarity NPD2534 Approved
0.7235 Intermediate Similarity NPD2532 Approved
0.7235 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7235 Intermediate Similarity NPD2533 Approved
0.7235 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7233 Intermediate Similarity NPD2798 Approved
0.7231 Intermediate Similarity NPD8319 Approved
0.7231 Intermediate Similarity NPD8320 Phase 1
0.7222 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7219 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7212 Intermediate Similarity NPD7033 Discontinued
0.7179 Intermediate Similarity NPD7680 Approved
0.7169 Intermediate Similarity NPD6099 Approved
0.7169 Intermediate Similarity NPD6100 Approved
0.7168 Intermediate Similarity NPD3226 Approved
0.7166 Intermediate Similarity NPD8434 Phase 2
0.7166 Intermediate Similarity NPD8150 Discontinued
0.716 Intermediate Similarity NPD2313 Discontinued
0.7151 Intermediate Similarity NPD8127 Discontinued
0.7143 Intermediate Similarity NPD2800 Approved
0.7135 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7134 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7134 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7128 Intermediate Similarity NPD6841 Approved
0.7128 Intermediate Similarity NPD6843 Phase 3
0.7128 Intermediate Similarity NPD6842 Approved
0.7126 Intermediate Similarity NPD2346 Discontinued
0.712 Intermediate Similarity NPD4360 Phase 2
0.712 Intermediate Similarity NPD4363 Phase 3
0.712 Intermediate Similarity NPD5953 Discontinued
0.7108 Intermediate Similarity NPD2799 Discontinued
0.7104 Intermediate Similarity NPD7286 Phase 2
0.7091 Intermediate Similarity NPD6651 Approved
0.7086 Intermediate Similarity NPD6386 Approved
0.7086 Intermediate Similarity NPD6385 Approved
0.7076 Intermediate Similarity NPD7390 Discontinued
0.7072 Intermediate Similarity NPD5242 Approved
0.7068 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7068 Intermediate Similarity NPD6213 Phase 3
0.7068 Intermediate Similarity NPD6212 Phase 3
0.7055 Intermediate Similarity NPD6798 Discontinued
0.7048 Intermediate Similarity NPD7097 Phase 1
0.7041 Intermediate Similarity NPD5006 Approved
0.7041 Intermediate Similarity NPD5005 Approved
0.7037 Intermediate Similarity NPD4908 Phase 1
0.703 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.703 Intermediate Similarity NPD6355 Discontinued
0.703 Intermediate Similarity NPD5124 Phase 1
0.7012 Intermediate Similarity NPD6233 Phase 2
0.7006 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.6989 Remote Similarity NPD7615 Clinical (unspecified phase)
0.6975 Remote Similarity NPD9494 Approved
0.6975 Remote Similarity NPD3018 Phase 2
0.6971 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6957 Remote Similarity NPD1203 Approved
0.6957 Remote Similarity NPD8155 Clinical (unspecified phase)
0.6952 Remote Similarity NPD7549 Discontinued
0.6951 Remote Similarity NPD4907 Clinical (unspecified phase)
0.6951 Remote Similarity NPD3268 Approved
0.6937 Remote Similarity NPD4379 Clinical (unspecified phase)
0.6923 Remote Similarity NPD7229 Phase 3
0.6923 Remote Similarity NPD2344 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data